Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium

We investigated effectiveness of (1) mRNA booster vaccination versus primary vaccination only and (2) heterologous (viral vector–mRNA) versus homologous (mRNA–mRNA) prime-boost vaccination against severe outcomes of BA.1, BA.2, BA.4 or BA.5 Omicron infection (confirmed by whole genome sequencing) am...

Descripción completa

Detalles Bibliográficos
Autores principales: Meurisse, Marjan, Catteau, Lucy, van Loenhout, Joris A. F., Braeye, Toon, De Mot, Laurane, Serrien, Ben, Blot, Koen, Cauët, Emilie, Van Oyen, Herman, Cuypers, Lize, Robert, Annie, Van Goethem, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961733/
https://www.ncbi.nlm.nih.gov/pubmed/36851257
http://dx.doi.org/10.3390/vaccines11020378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961733/
https://www.ncbi.nlm.nih.gov/pubmed/36851257
http://dx.doi.org/10.3390/vaccines11020378

Ejemplares similares